6-31116972-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001264.5(CDSN):c.643C>A(p.Gln215Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001264.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001264.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDSN | NM_001264.5 | MANE Select | c.643C>A | p.Gln215Lys | missense | Exon 2 of 2 | NP_001255.4 | ||
| PSORS1C1 | NM_014068.3 | MANE Select | c.-229+2081G>T | intron | N/A | NP_054787.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDSN | ENST00000376288.3 | TSL:1 MANE Select | c.643C>A | p.Gln215Lys | missense | Exon 2 of 2 | ENSP00000365465.2 | ||
| PSORS1C1 | ENST00000259881.10 | TSL:1 MANE Select | c.-229+2081G>T | intron | N/A | ENSP00000259881.9 | |||
| PSORS1C1 | ENST00000479581.5 | TSL:1 | n.61+2081G>T | intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 72
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.643C>A (p.Q215K) alteration is located in exon 2 (coding exon 2) of the CDSN gene. This alteration results from a C to A substitution at nucleotide position 643, causing the glutamine (Q) at amino acid position 215 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at